Observation versus treatment among men with favorable risk prostate cancer in a community-based integrated health care system: a retrospective cohort study-Reference-Cited by-同舟云学术

Observation versus treatment among men with favorable risk prostate cancer in a community-based integrated health care system: a retrospective cohort study

Published:2018-06-04 Issue:1 Volume:18 Page:
ISSN:1471-2490
Container-title:BMC Urology
language:en
Short-container-title:BMC Urol

Author:

Kariburyo Furaha,Wang Yuexi,Cheng I-Ning,Wang Lisa,Morgenstern David,Xie Lin,Meadows Eric,Danella John,Cher Michael L.

Funder

Roche

Publisher

Springer Science and Business Media LLC

Subject

Urology,Reproductive Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12894-018-0372-1.pdf

Reference25 articles.

1. Polascik TJ, Passoni NM, Villers A, Choyke PL. Modernizing the diagnostic and decision-making pathway for prostate cancer. Clin Cancer Res. 2014;20(24):6254–7.

2. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med. 2012;366(11):981–90.

3. Roobol MJ, Kerkhof M, Schröder FH, Cuzick J, Sasieni P, Hakama M, et al. Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European randomised study of screening for prostate Cancer (ERSPC). Eur Urol. 2009;56(4):584–91.

4. Mottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, et al. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Actas Urol Esp. 2011;35(10):565–79.

5. Eldefrawy A, Katkoori D, Abramowitz M, Soloway MS, Manoharan M. Active surveillance vs. treatment for low-risk prostate cancer: a cost comparison. Urol Oncol. 2013;31(5):576–80.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients with Idiopathic Membranous Nephropathy: A Real-World Clinical and Economic Analysis of U.S. Claims Data;Journal of Managed Care & Specialty Pharmacy;2019-09

2. The current landscape of low-value care in men diagnosed with prostate cancer: what is the role of individual hospitals?;Urologic Oncology: Seminars and Original Investigations;2019-09

3. Hypofractionated Proton Therapy in Early Prostate Cancer: Results of a Phase I/II Trial at Loma Linda University;International Journal of Particle Therapy;2019-06-01